Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-26-055727
Filing Date
2026-05-05
Accepted
2026-05-05 17:11:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2611538d5_defa14a.htm DEFA14A 16381
2 GRAPHIC tm2611538d5_defa14aimg001.jpg GRAPHIC 215082
3 GRAPHIC tm2611538d5_defa14aimg002.jpg GRAPHIC 116114
  Complete submission text file 0001104659-26-055727.txt   467766
Mailing Address 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017 833-393-6684
HYPERION DEFI, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38365 | Film No.: 26944559
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)